Written question asked by Clive Jones (Liberal Democrat) on Thursday, 6 February 2025, in the House of Commons. It was due for an answer on Monday, 10 February 2025. It was answered by Feryal Clark (Labour) on Friday, 14 February 2025 on behalf of the Department for Science, Innovation and Technology.
Astrazeneca
- Question
-
To ask the Secretary of State for Science, Innovation and Technology, with reference to the oral contribution by the hon. Member for Havant of 3 February 2025, Official Report, column 552, for what reason the letter from AstraZeneca of 9 July 2025 to the Chancellor of the Exchequer and the Secretary of State for Science, Innovation and Technology received a delayed response.
- Answer
-
The Government has had numerous discussions with AstraZeneca about their proposed investment into Speke. There were minor delays in replying to correspondence following the election period.
Secondary information
- Type
- Written question
- Reference
- 29742
- Session
- 2024-26
- Related items
- Registered interest declared
- Yes
- Subjects
- Correspondence AstraZeneca
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 20:27:30 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/29742
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/29742
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/29742